Fuji Pharma Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Takayuki Iwai

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure5.5yrs
CEO ownership0.04%
Management average tenureno data
Board average tenure4.6yrs

Recent management updates

Recent updates

Fuji Pharma (TSE:4554) Is Increasing Its Dividend To ¥22.50

Jul 03
Fuji Pharma (TSE:4554) Is Increasing Its Dividend To ¥22.50

Fuji Pharma (TSE:4554) Has Announced That It Will Be Increasing Its Dividend To ¥22.50

Jun 19
Fuji Pharma (TSE:4554) Has Announced That It Will Be Increasing Its Dividend To ¥22.50

Impressive Earnings May Not Tell The Whole Story For Fuji Pharma (TSE:4554)

May 21
Impressive Earnings May Not Tell The Whole Story For Fuji Pharma (TSE:4554)

Fuji Pharma (TSE:4554) Will Pay A Larger Dividend Than Last Year At ¥22.50

May 13
Fuji Pharma (TSE:4554) Will Pay A Larger Dividend Than Last Year At ¥22.50

Fuji Pharma's (TSE:4554) Dividend Will Be ¥20.00

Feb 28
Fuji Pharma's (TSE:4554) Dividend Will Be ¥20.00

CEO

Takayuki Iwai (60 yo)

5.5yrs

Tenure

Mr. Takayuki Iwai is President & CEO of Fuji Pharma Co., Ltd. from November 2019. He joined the Fuji Pharma Co., Ltd.in October 2019. He was President of Fuji Pharma Co., Ltd. from 2019 to November 2019.


Board Members

NamePositionTenureCompensationOwnership
Toyoyuki Kamide
VP, Executive Officer & Directorno datano data0.079%
¥ 29.5m
Hirofumi Imai
Chairman33.6yrsno data34.38%
¥ 12.8b
Fujiaki Mimura
Outside Audit & Supervisory Board Member20.6yrsno data0.030%
¥ 11.3m
Satoshi Suzuki
Vice President & Director1.6yrsno data0.00019%
¥ 70.8k
Keiji Hirai
Independent Outside Director7.6yrsno data0.021%
¥ 8.0m
Shuhei Morita
Directorless than a yearno data0.0059%
¥ 2.2m
Minesaburo Miyake
Independent Outside Director6.6yrsno data0.021%
¥ 8.0m
Miori Sagara
Outside Audit & Supervisory Board Member4.6yrsno data0.0045%
¥ 1.7m
Keiko Kiyama
Independent Outside Director3.6yrsno data0.0021%
¥ 767.3k
Yukiko Araki
Independent Outside Director3.6yrsno data0.00082%
¥ 305.4k
Daiji Ojima
Audit & Supervisory Board Chairmanno datano data0.033%
¥ 12.3m

4.6yrs

Average Tenure

61yo

Average Age

Experienced Board: 4554's board of directors are considered experienced (4.6 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.